RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.

Add to Collection
2009 Sep RCTs Fist_Author_Year_PM

Full Author : ['Chacra, A R', 'Tan, G H', 'Apanovitch, A', 'Ravichandran, S', 'List, J', 'Chen, R']
Journal Title : International journal of clinical practice
Chapter : Section25, Section2, Section4
Journal Year : 2009

AIMS: Assess the efficacy and safety of saxagliptin added to a submaximal sulphonylurea dose vs. uptitration of sulphonylurea monotherapy in patients with type 2 diabetes and inadequate glycaemic control with sulphonylurea monotherapy. METHODS AND PATIENTS: A total of 768 patients (18-77 years; HbA(1c) screening >or= 7.5 to

Keywords : ['sulphonylurea improve glycaemic control compare', 'randomise control trial', 'type diabete', 'submaximal dose', 'saxagliptin add', 'sulphonylurea', 'uptitration', 'patient']